ArticlePDF Available

Rubia cordifolia: a review

  • Gokhale Education Society's Sir Dr. M.S. Gosavi College of Pharmaceutical Education & Research, Nashik, Maharashtra
  • Mahatma Gandhi Vidyamandir's Pharmacy College, Nashik, Maharashtra, INDIA
  • Rajarshi Shahu College of pharmacy


Medicinal herbs are significant source of synthetic and herbal drugs. In the commercial market, medicinal herbs are used as raw drugs, extracts or tinctures. Isolated active constituents are used for applied research. For the last few decades, phytochemistry (study of plants) has been making rapid progress and herbal products are becoming popular. According to Ayurveda, the ancient healing system of India, the classical texts of Ayurveda, Charaka Samhita and Sushruta Samhita were written around 1000 B.C. The Ayurvedic Materia Medica includes 600 medicinal plants along with therapeutics. Herbs like turmeric, fenugreek, ginger, garlic and holy basil are integral part of Ayurvedic formulations. The formulations incorporate single herb or more than two herbs (poly-herbal formulations). Medicinal herb contains multitude of chemical compounds like alkaloids, glycosides, saponins, resins, oleoresins, sesquiterpene, lactones and oils (essential and fixed). Today there is growing interest in chemical composition of plant based medicines. Several bioactive constituents have been isolated and studied for pharmacological activity. R. cordifolia is an important medicinal plant commonly used in the traditional and Ayurvedic system of medicine for treatment of different ailments. This review illustrates its major constituents, pharmacological actions substantiating the claims made about this plant in the traditional system of medicine and its clinical applications.
2009 Kyung Hee University Press 1
Oriental Pharmacy and Experimental Medicine 2009 9(1), 1-13
Rubia cordifolia: a review
Rupali Patil*, Mahalaxmi Mohan, Veena Kasture and Sanjay Kasture
MGVs Pharmacy College, Panchavati, Nashik 422 003, Maharashtra State, India
Received for publication December 17, 2007; accepted November 25, 2008
Medicinal herbs are significant source of synthetic and herbal drugs. In the commercial market,
medicinal herbs are used as raw drugs, extracts or tinctures. Isolated active constituents are used
for applied research. For the last few decades, phytochemistry (study of plants) has been making
rapid progress and herbal products are becoming popular. According to Ayurveda, the ancient
healing system of India, the classical texts of Ayurveda, Charaka Samhita and Sushruta Samhita
were written around 1000 B.C. The Ayurvedic Materia Medica includes 600 medicinal plants
along with therapeutics. Herbs like turmeric, fenugreek, ginger, garlic and holy basil are integral
part of Ayurvedic formulations. The formulations incorporate single herb or more than two herbs
(poly-herbal formulations). Medicinal herb contains multitude of chemical compounds like
alkaloids, glycosides, saponins, resins, oleoresins, sesquiterpene, lactones and oils (essential and
fixed). Today there is growing interest in chemical composition of plant based medicines. Several
bioactive constituents have been isolated and studied for pharmacological activity. R. cordifolia is
an important medicinal plant commonly used in the traditional and Ayurvedic system of
medicine for treatment of different ailments. This review illustrates its major constituents,
pharmacological actions substantiating the claims made about this plant in the traditional system
of medicine and its clinical applications.
Key words: Rubia cordifolia; Ayurveda; Clinical applications
The family Rubiaceae comprises of about 450
genera and 6500 species and includes trees, shrubs
and herbs (Williams, 2002). Rubia comprises about
60 species. R. cordifolia Linn. (Rubiaceae) is a perennial
climber with very long, cylindrical, flexuose roots
with a thin red bark (Kirtikar and Basu, 1980). In
Sanskrit it is known as Manjistha. This plant has
very long, cylindrical, and flexuous roots with a
thin red colored bark (Anonymous, 1999). Stems
often have a long, rough, grooved, woody base.
Plants belonging to this family are known to
contain substantial amounts of anthraquinones,
especially in the roots (Thomson, 1971; Anonymous,
1999). Flowers are small, white or greenish in
terminal panicles or cymes. Fruits are globose, dark
purplish or black (Williams, 2002). It is distributed
throughout the lower hills of Indian Himalayas in
the North and Western Ghats in the South, and
Japan, Indonesia, Ceylon, Malay, Peninsula, Java
*Correspondence: Rupali Patil, MGVs Pharmacy College,
Panchavati, Nashik-422003 Maharashtra, India. E-mail:
DOI 10.3742/OPEM.2009.9.1.001
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
2Rupali Patil et al.
and Tropical Africa in moist temperature and
tropical forest, upto an altitude of 3500 m. (Kirtikar
and Basu, 1980; Khare, 2004).
R. cordifolia is used traditionally in the treatment
of liver fluke, dysentery, maggots, wounds and
intestinal worms in animals (Jha, 1992). It is used in
the treatment of skin disorders and has anticancer
activity (Chopra et al., 1957; Adwankar and Chitnis,
1982; Williams, 2002). Roots have tonic, astringent,
antidysenteric, antiseptic, and deobstruent properties.
They are used in rheumatism. Roots are active
against Staphylococcus aureus. Paste of root is
used for application in ulcers, inflammations, and
skin conditions. A decoction of leaves and stems is
used as a vermifuge (Williams, 2002). Scientific
studies show that the anthraquinones of the Rubiaceae
family exhibit some interesting in vivo biological
activities, such as antimicrobial (Sittie et al., 1999),
antifungal (Rath et al., 1995), hypotensive, analgesic
(Younos et al., 1990), antimalarial (Adwankar and
Chitnis, 1982; Koumaglo et al., 1992), antioxidant
(Tripathi et al., 1997), antileukemic and mutagenic
functions (Chang et al., 1995; Ismail et al., 1997).
Apart from its medicinal value, this plant has also
been used as natural food colorants and as natural
hair dye (Samatha et al., 1996). R. cordifolia is often
used in formulations to treat uterine and ovarian
cancer (Halpern, 2004).
Ayurvedic Properties (Williams EM; CHEMEXIL)
Rasa: Kashaya (astringent), tikta (bitter), madhur
Guna: Guru (heavy), ruksha (dry)
Veerya: Ushna (hot)
Vipaka: Katu (pungent)
Dosha: Pacifies kapha and pitta
Karma: Varnya, Jwarhara, Mutrajanya, Swwdajanana,
Chemical constituents
The plant contains quinines, mainly anthraquinone
glycosides and include 1-hydroxy 2-methoxy
anthraquinone, 1, 4- dihydroxy-2- methyl-5-methoxy
anthraquinone, 1,3- dimethoxy 2- carboxy
anthraquinone and rubiadin) (Dosseh et al., 1981).
6-methoxygeniposidic acid is found along with
manjistin, garancin and alizarin (Wu et al., 1991).
Oleananes triterpinoid
Rubiprasin A, B, and C along with arborane
triterpinoids, like rubiarbonol A, B, C, D, E and F
have been isolated (Itokawa et al., 1989; Itokawa et
al., 1990).
Bicyclic hexapeptides
The compounds having antitumour activity have
been isolated and identified chemically. (Morita et
al., 1992; Takeya et al., 1993).
The coloring matter present in the roots of R. cordifolia is
a mixture of purpurin (trihydroxy anthraquinone)
and manjistin (xanthopurpurin-2-carboxylic acid).
The roots contain small amounts of xanthopurpurin or
purpuroxanthin and pseudopurpurin (purpurin-3-
carboxylic acid) (Anonymous, 1999). The plant also
contains dihydromollugin, mollugin, rubilactone
(Hoa LK et al., 2001). Purpurin, belonging to the
lipocalin family of proteins, is a fast dye for cotton
printing and forms complexes with various metal
ions. It is a glycosaminoglycan binding protein as
well as a retinol binding protein.
Alizarin, or 1, 2-dihydroxyanthraquinone or
mordant red, is the red dye originally derived from
the root of the madder plant. In 1869, it became the
first natural pigment to be duplicated synthetically.
The word alizarin is derived from the Arabic word
al-usara, which means juice.
R. cordifolia yielded anthraquinones namely, 1-
hydroxy-2 carboxy 3-methoxyanthraquinone, 1-
hydroxy-2 methyl 6 or 7-methoxy- anthraquinones.
The other compounds were oleanolic acid acetate,
β-sitosterol, and scopoletol. Ten fatty acids with
Rubia cordifolia: a review 3
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
saturated and unsaturated long chains were also
identified (Vidal-Tessier et al., 1986).
The methanol extract of R. cordifolia roots
contains 2 naphthaquinones (Koyama et al., 1992).
2-carbamoyl/2-caurbomyl-3-methoxy-1,4- naphtha-
quinones and 2-carbamoyl-3-hydroxy-1,4- naphtha-
Anthraquinones from R. cordifolia:
Alizarin (1, 2-dihydroxy-9,10-anthracenedione)
Purpurin (1, 2, 4-trihydroxyanthracene-9, 10-Dione)
No R R
1 COOMe OH Mollugin
2 COOMe OH Furomollugin
3 COOMe OH Rubilactone
4 COOMe OMe Methylfuromollugin
5 COOMe OMe Mollugin methyl ether
6 COOMe OH Dihydromollugin
7 COOMe OAc Acetylmollugin
10 C OOMe OMe Dihydromollugin methyl ether
11 COOMe OMe Methylrubilactone
12 CO OH OM e 2, 2-Dimethyl-6-methoxy-2H-naph-
tho-[1,2-b]pyran-5-carboxylic acid
#I - Isopentyl 2, 2-dimethyl-6-methoxy-2H-naphtho-[1,2-b] pyran-5-car
#II - Methyl 2, 2-dimethyl-6-benzoxy-2H-naphtho-[1,2-b] pyran-5-carbox
ylate (Morita et al., 1992).
Qiao et al. (1990) isolated 12 compounds from roots of R.cordifolia of which
9 compounds have been characterized by chemical and spectroscopic
methods as -
1. Alizarin
2. 1-hydroxy-2-methyl-9,10-anthraquinone
3. 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6’-o-acetyl)-alpha-L-
rhamnosyl (1 to 2) – beta- D-glucoside
4. 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-alpha-L-rhamnosyl
(1 to 2)–beta- D-glucoside
5. 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6’-o-acetyl)-beta-D-
6. 2-carbomethoxy-3-pr enyl-1-4-naphthohydroquinone di-beta-D-glucoside
7. Rubimallin
8. β-sitosterol
9. Damosterol
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
4Rupali Patil et al.
Bicyclic hexapeptides from R. cordifolia:
RA-XVI (Takeya et al., 1993)
Traditional uses in different systems of herbal
Unani system of medicine
R. cordifolia has been prescribed for paralysis, dropsy,
jaundice, amenorrhoea, urinary tract obstructions,
skin disorders of many varieties, menstrual disorders
(excessive or painful bleeding), renal stone, urinary
disorders and blood detoxification (www.
Chinese system of medicine: Roots help menstrual
flow, promote blood circulation, promote urination,
stop coughing blood or vomiting blood, nose bleeding.
The plant is also useful in treatment of missing
menses due to blood stasis, cold damp heat bi
(pain and inflammation caused by bleeding and
blood circulation stasis), injuries from impacts and
in jaundice and edema (
Ethnoveterinary usage
R. cordifolia is used in the treatment of liver fluke,
dysentery, maggots, wounds and intestinal worms
in animals (Jha, 1992).
Pre-Clinical Studies
In vitro studies
Rubia cordifolia: a review 5
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
Calcium channel blocker(s) in R. cordifolia
The calcium channel antagonistic activity of a
crude root extract of R. cordifolia was tested in
isolated tissue preparations. The extract (0.1 - 3
mg/ml) augmented spontaneous contractions of
guinea pig atria, rabbit jejunum and rat uterus in a
concentration-dependent manner. In rabbit aorta,
the extract inhibited norepinephrine-(10 fM) and
KCl (80 mM) induced contractions. Spontaneous
movements of rabbit jejunum were abolished in a
calcium-free solution. Addition of calcium (25 fg/ml)
restored the spontaneous movements. When tissues
were pretreated with plant extract (1 mg/ml) or
verapamil (0.5 fg/ml), addition of calcium failed to
restore spontaneous contractions. These results
indicate that the extract exhibits spasmolytic activity
similar to that of verapamil suggestive of presence
of calcium channel blocker- like constituent(s)
(Gilani et al., 1994).
Anti-acne property
Propionibacterium acnes, an anaerobic pathogen,
plays an important role in the pathogenesis of acne
by inducing certain inflammatory mediators.
These mediators include reactive oxygen species
(ROS) and pro-inflammatory cytokines. In the
study, ROS, interleukin-8 (IL-8) and tumor necrosis
factor-Y (TNF-Y) were used as the major criteria for
the evaluation of anti-inflammatory activity. The
polymorphonuclear leukocytes (PMNL) and monocytes
were treated with culture supernatant of P. acnes in
the presence or absence of herb. It was found that
R. cordifolia caused a statistically significant
suppression of ROS from PMNL. Thus, R. cordifolia
Table 1. Some of the ayurvedic preparations containing R. cordifolia Linn. (Rubiaceae)
Sr. no. Name of preparation Indications Citations
1 Aswagandharistam
Epilepsy, faintness, fatigue, psychic problems, piles,
indigestion, rheumatic complaints etc. Improves mem-
ory power.
2 Chandanasavam
Burning micturition, leucorrhocat etc. Improves body
strength and digestive system. Keeps the body cool
and also maintain good general health.
3 Devadarvarishtam Diabetes, rheumatic complaints, sprue syndrome,
piles, difficult urination, skin diseases etc. Baishajyaratnavali
4 Eladyarishtam Chickenpox, skin diseases like urticaria, dermatitis
and allergic itching Yogaratnakaram
5 Gulguluthikthkarishtam
Recommended in acute rheumatic conditions, chronic skin
diseases, sinusitis, lymph adunosis, diseases related with
head, neck and throat, abscess and obesity.
6 Madhookasavam Diabetes, skin diseases, sprue syndrome and oedema.
Also as a tonic for general well-being. Ashtangahridayam
7 Manjishtasavam For all types of skin diseases and vatha sonitha,
especially for vitiated pitha and kapha vikaras. Ashtangahridayam
8 Nimbamrithasavam
Recommended in acute rheumatic conditions, skin
diseases, and sinusitis, obesity, and lymph adenoids
around neck, diseases related with head, neck and
throat abscess.
9 Useerasavam For burning sensation of head and body, vertigo,
disturbed sleep, tachycardia etc. Yogaratnakaram
10 Jaatyaadi ghrita Applied externally for chronic and septic ulcers Ashtaanga Hridaya
11 Phal kalyaan ghrita Used for amenorrhea and uterine affections Bhaishajya Ratnaavali
12 Majishthaadi taila Used for headache Sahasrayoga
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
6Rupali Patil et al.
showed anti-inflammatory activity by suppressing
the capacity of P. acnes-induced ROS and pro-
inflammatory cytokines, the two important
inflammatory mediators in acne pathogenesis (Jain
and Basal, 2003).
Antimicrobial action
R. cordifolia is used as a dye from natural sources
therefore a study was taken up to test if some
natural dyes have inherent antimicrobial activity
with a view to develop protective clothing from
these. R. cordifolia was tested against common
pathogens Escherichia coli, Bacillus subtilis, Klebsiella
pneumoniae, Proteus vulgaris and Pseudomonas aeruginosa.
The textile material impregnated with these natural
dyes, however, showed less antimicrobial activity,
as uptake of these dyes in textile material is below
MIC. The antibacterial activity of the extracts of R.
cordifolia roots prepared with solvents of different
successive polarities was evaluated by the agar-
well diffusion method. It inhibited both gram
positive and gram negative strains (Singh et al.,
2005; Vlietinck, 1995). Many compounds were
isolated, established by chemical and spectroscopic
methods from the roots of R. cordifolia L. Some of
the compounds showed certain antibacterial activities
(Qiao et al., 1990). In one study some antimicrobial
agents, emodin and physcion were isolated as the
most active constituents (Basu et al, 2005).
In vivo studies
Antidiabetic Action
The antidiabetic action of R. cordifolia Linn (Rubiaceae)
aqueous root extract (RCAREt) was examined in
streptozotocin (STZ)-induced diabetic rat model.
Serum glucose, total cholesterol and triglycerides,
hematological parameters, and liver and kidney
transaminases in normal, STZ diabetic, and RCAREt-
treated diabetic rats were measured. The observed
hyperglycemia, hypertriglyceridemia, enhanced
transaminases of liver and kidney, hypochromic
microcytic anemia, and loss of body weight in STZ
diabetic rats were normalized by RCAREt treatment,
whereas the hypercholesterolemia was not rectified.
The beneficial effect of RCAREt treatment might be
due to different types of active principles, each with a
single or a diverse range of biological activities (Baskar
et al., 2006). The effect of ethyl acetate fraction of
roots of R. cordifolia (RCEAF) was investigated on
blood glucose level and glucose utilization to find
out the mechanism of action of the extract. Ethanolic
extract of roots of R. cordifolia L. was reported to be
hypoglycemic and it was fractionated by column
chromatography. Single dose study of RCEAF (50,
100 and 200 mg/kg, p.o.) was carried out in i)
normal fasted ii) oral glucose tolerance test (OGTT)
iii) alloxan (120 mg/kg, s.c.)- induced diabetic rats.
Repeated dose study of RCEAF (100 and 200 mg/kg,
p.o.) was carried out for two weeks. It was found
that, oral pre-treatment with RCEAF induced a
significant (P< 0.05) decrease in blood glucose
levels as compared to diabetic control rats. In the
same line an in vitro experiment showed that
insulin (0.05 IU/mL) increased glucose utilization
by an isolated rat diaphragm. Alone RCEAF (25
mg/mL) as well as combination of RCEAF (25
mg/mL) and insulin (0.05 IU/mL) showed a
marked increase (P < 0.05) of glucose uptake. This
exhibited the extra- pancreatic effect of the RCEAF.
Further studies with estimation of insulin and
insulin receptor may give more insight into the
mechanism of the antidiabetic activity of the R.
cordifolia (Somani et al., 2006). Administration of the
alcoholic extract of roots of R. cordifolia showed
significant hypoglycemic effect in alloxan induced
diabetic rats (Patil et al., 2006).
Anti-oxidant activity
Prolonged oral treatment of rats with ethanol (2 g/kg
of 20% w/v) significantly increased the levels of
lipid peroxidase (LPO), decreased the activities of
superoxide dismutase (SOD) and catalase (CAT)
and reduced the content of glutathione (GSH). The
concurrent treatment of ethanol-administered rats
with R. cordifolia prevented these above mentioned
ethanol-induced changes in the markers of oxidative
Rubia cordifolia: a review 7
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
stress. Influences of R. cordifolia on ethanol-induced
changes were comparable with those produced by
vitamin E and C treatment (Joharanpurkar et al., 2003).
Rubiadin, a dihydroxy anthraquinone, isolated
from alcoholic extract of R. cordifolia, possesses potent
antioxidant property. It prevents lipid peroxidation
induced by FeSO4 and t-butylhydroperoxide (t-
BHP) in a dose-dependent manner. The percent
inhibition was more in the case of Fe2+ induced
lipid peroxidation. The antioxidant property of the
preparation was better than the EDTA, Tris,
mannitol, Vitamin E and p-benzoquinone (Tripathi
et al., 1997).
Antiproliferative activity
The antiproliferative property of R. cordifolia extract
has been studied on two different cell types, A-431
cells (epidermal carcinomoid cells) and 3T3 fibroblast
cells. A fraction of R. cordifolia significantly inhibited
the incorporation of 3H-thymidine induced by
fetal bovine serum, in a dose-dependent manner. It
also inhibited the phorbol 12-myristate 13-acetate
(PMA)-induced expression of c-fos genes in A-431
cells. Inhibition of DNA synthesis underlies the
mechanism for its antiproliferative properties
(Tripathi et al., 1998).
Hepatoprotective Activity
The hepatoprotective activity of an aqueous-
methanol extract of R. cordifolia was investigated
against acetaminophen and CCl4-induced hepatic
damage. Acetaminophen produced 100% mortality
at a dose of 1 g/kg in mice while pretreatment of
animals with R. cordifolia extract reduced mortality
to 30%. Acetaminophen at a dose of 640 mg/kg
produced liver damage in rats as manifested by the
rise in serum levels of glutamic oxaloacetic transaminas e
(SGOT) and glutamate pyruvate transaminase (SGPT).
Pretreatment of rats with R. cordifolia extract lowered
significantly the SGOT and SGPT levels. Similarly,
hepatotoxic dose of CCl4 raised the SGOT and
SGPT levels respectively compared with respective
control. The same dose of R. cordifolia was able to
prevent significantly the CCl4-induced rise in
serum enzymes and the estimated values of SGOT
and SGPT. Moreover, it prevented CCl4-induced
prolongation in pentobarbital-induced sleep
confirming the hepatoprotective effects of the
extract (Gilani et al., 1995).
The hepatoprotective activity of rubiadin was
evaluated against carbon tetrachloride (CCl4)-induced
hepatic damage in rats. Rubiadin at a dose of 50,
100 and 200 mg/kg was administered orally once
daily for 14 days. The substantially elevated serum
enzymatic activities of SGOT, SGPT, serum alkaline
phosphatase (SALP) and γ-glutmyltransferase (γ-GT)
due to carbon tetrachloride treatment were dose
dependently restored towards normalization.
Meanwhile, the decreased activities of glutathione
S-transferase and glutathione reductase were also
restored towards normal. In addition, rubiadin also
significantly prevented the elevation of hepatic
melondialdehyde formation and depletion of
reduced glutathione content in the liver of CCl4
intoxicated rats in a dose dependent manner.
Silymarin used as reference standard also exhibited
significant hepatoprotective activity on post treatment
against carbon tetrachloride induced hepatotoxicity in
rats. The biochemical observations were supplemented
with histopathological examination of rat liver
sections. The results of this study strongly indicate
that rubiadin has a potent hepatoprotective action
against carbon tetrachloride induced hepatic
damage in rats (Mohana et al., 2006).
Anti-platelet activating factor activity
R. cordifolia is clinically used for the purification of
blood by the physicians of the Indian Systems of
Medicine. The effect of the partially purified
fraction of this whole plant had been studied on
rabbit platelets. It inhibited the platelet aggregation
induced by PAF (platelet activating factor) but not
thrombin. PAF (platelet activating factor) is a
phospholipids involved in thrombosis, allergy and
nervous disorders. R. cordifolia extract also inhibited
the binding of 3H labeled-PAF to the platelets in
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
8Rupali Patil et al.
the dose-dependent manner. Thus it appears that
R. cordifolia inhibits action of PAF at its receptor
level either by its blocking or by desensitization
(Tripathi et al., 1993).
Antitumour activity
The cyclic hexapeptides and quinones of Rubia
exhibited a significant anticancer activity against
various proliferating cells. The hexapeptides showed
potent antitumour activity by binding to eukaryotic
80S ribosomes resulting in inhibition of aminoacyl
-tRNA binding and peptidyl – tRNA translocation,
thus leading to the stoppage of protein synthesis
(Morita, 1992, Morita, 1993, Itokawa, 1993). The
antitumor activity of RA-700, a cyclic hexapeptide
isolated from R. cordifolia, was evaluated in
comparison with deoxy-bouvardin and vincristine
(VCR). The antitumor activity of RA-700 was
similar to that of deoxy-bouvardin and VCR
against P388 leukemia. As with deoxy-bouvardin
and VCR, the therapeutic efficacy of RA-700 depends
on the time schedule. RA-700 showed marginal
activity against L1210 leukemia (50% ILS), similar
to that of deoxy-bouvardin but inferior to that of
VCR. RA-700 inhibited Lewis tumor growth in the
early stage after tumor implantation, whereas
deoxy-bouvardin and VCR did not. A slight
reduction of peripheral WBC counts was observed
with the drug, but no reduction of RBC and
platelet counts. Bilirubin, creatinine, GPT and GOT
levels in plasma did not change with the administration
of the drug (Kato, 1987). The anticancer as well as
antiviral property had been reviewed (Rastogi and
Dhawan, 1990). From the chloroform fraction of R.
cordifolia roots three constituents were isolated
namely mollugin, furomollugin and dehydro-a-
lapchone. Mollugin has shown inhibition of passive
cutaneous anaphylaxis (PCA) and protection of
mast cell degranulation in rats. It also exhibited
considerable activity against lymphoid leukemia
(P338) in mice (Gupta, 1999). The R. cordifolia
extract had shown a mitodepressive effect on the
rate of cell division in bone marrow cells of Swiss
male mice. This exposure-time-dependent reduction
was attributed to the effect of inhibiting protein
synthesis, suggesting probable effect of Rubia
extract on the biosynthesis of certain amino acids
as well as RNA synthesis (Abderrahman, 2004). R.
cordifolia had shown an increase in leukocyte count
in leucopenia (Zhang, 1983).
The cytotoxic action of R. cordifolia had been
evaluated with DNA Topoisomerases I and II
inhibition and cytotoxicity of constituents isolated
from the roots was tested. Topoisomerases I and II
inhibitory activities were measured by assessing
the relaxation of supercoiled pBR 322 plasmid
DNA. The tetrazolium-based colorimetric assay
(MTT assay) was used for the cytotoxicity towards
human colon carcinoma (HT-29), human breast
carcinoma (MCF-7) and human liver carcinoma
(HepG2) cell lines. Seven compounds were isolated
possessing cytotoxic activity (Son JK, 2006). Anti-
tumor activity of RC-18, a pure isolate from R.
cordifolia, was repeatedly tested in different sets of
experiments on a spectrum of experimental murine
tumors, viz P388, L1210, L5178Y, B16 melanoma,
Lewis lung carcinoma and sarcoma-180. RC-18
exhibited significant increase in life span of ascites
leukemia P388, L1210, L5178Y and a solid tumor
B16 melanoma. However, it failed to show any
inhibitory effect on solid tumors, Lewis lung
carcinoma and sarcoma 180. Promising results
against a spectrum of experimental tumors suggested
that RC-18 may lead to the development of a
potential anti-cancer agent (Adwankar and Chitnis,
1982). The anticancer activity of extracts of R.
cordifolia, tested against the P388 tumor system in
BDF1 mice, compared well with that of the positive
control, 5-fluorouracil (Adwankar et al., 1980).
Anti-inflammatory activity
R. cordifolia is considered to be traditionally useful
as an analgesic, astringent, external application in
inflammations, ulcers and skin diseases (Khalid,
1995). The plant is also claimed to relieve the
symptoms of pruritus, burning and exudation
Rubia cordifolia: a review 9
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
from skin (Nadkarni, 1976). During studies in
patients with eczema, the topical application of the
plant showed a 50 % reduction in the severity score
within 4 days, the oedema, exudation and itching
being significantly relieved (Bapalal, 1965). R.
cordifolia was studied for the anti-inflammatory
effect in rats with carrageenan paw oedema. The
plant showed significant anti-inflammatory activity at
a dose of 10 and 20 ml/kg of the water extracts. The
activity was comparable to that of phenylbutazone (100
mg/kg) (Antarkar et al, 1983). R. cordifolia inhibited
the lipoxygenase enzyme pathway and the production
of cumene hydroperoxides. The lipoxygenase
pathway catalyses the production of various
inflammatory mediators such as the leukotrienes
which are involved in asthma, arthritis, and other
inflammatory disorders (Tripathi et al, 1995).
Radioprotective effect
The radioprotective potential of alcoholic extract of
root of R. cordifolia was studied by survival,
hemopoietic cell protection and micronucleus
assay. The LD50 value for the alcoholic root extract
was found to be 1200 mg/kg body weight at 72 h
post irradiation. A significant radiation protection
(67%) as assessed by increased animal survival was
observed when R. cordifolia extract was administered
intraperitoneally, 90 min. before the radiation
exposure. Besides, the extract also inhibited
radiation induced lipid peroxidation measured by
the inhibition of thiobarbituric acid reactive
substance (TBARS). The R. cordifolia extract at a
selected dose of 460 mg/kg body weight was
effective in protecting the radiation induced
suppression of endogenous colony forming units
in spleen. A significant inhibition of radiation-
induced micronuclei formation was observed
when R. cordifolia extract was administered 90 min
prior to irradiation. Thus, it appears that the
alcoholic root extract of R. cordifolia provides
significant protection against radiation induced
lipid peroxidation, hemopoietic injury and genotoxicity.
The mechanism of action of R. cordifolia extract
appears to be through its anti-oxidant, metal
chelation and anti-inflammatory property (Tripathi
and Singh, 2007).
Anti-proliferative property
Psoriasis is a chronic inflammatory skin disorder,
which affects approximately 2 - 3% of the population
worldwide. Traditionally, herbal medicines have
been extensively used to treat psoriasis and
produced promising clinical results; however, the
underlying mechanisms of action have not been
systematically investigated. Roots of R. cordifolia L
were extracted with 80% aqueous ethanol. The dry
extract was evaluated for anti-proliferative activity
by microplate SRB and MTT assays. It was found
to have significant anti-proliferative effect, as
measured by MTT assay. R. cordifolia did not exert
cytotoxicity to this human fibroblast cell line (Tse et
al., 2006). The antiproliferative property of R.
cordifolia (Rubiaceae) extract was also tested on A-
431 cells (epidermal carcinomoid cells) and 3T3
fibroblast cells. It was observed that a fraction of R.
cordifolia significantly inhibited the incorporation
of [3H]-thymidine, induced by fetal bovine serum,
in a dosedependent manner. It also inhibited the
PMA (phorbol 12- myristate 13-acetate) induced
expression of c-fos genes in A-431 cells. It appears
that inhibition of DNA synthesis underlies the
mechanism for its antiproliferative properties
(Tripathi and Shukla, 1998).
Inhibitory action on nitric oxide production
R. cordifolia is used for prevention and treatment of
inflammatory diseases, therefore water and methanol
extracts of R. cordifolia were screened for their
inhibitory effects on nitric oxide (NO) production
in lipopolysaccharide (LPS)-stimulated J774.1
macrophages and in LPS/interferon (IFN)-B-
stimulated mouse peritoneal exudate macrophages.
The methanol extract R. cordifolia, showed significant
inhibition in J774.1 macrophages, while in mouse
peritoneal exudate macrophages, water extract of
R. cordifolia inhibited the nitric oxide (NO)
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
10 Rupali Patil et al.
production. Water extract of R. cordifolia showed
inhibition on iNOS mRNA expression (Tezuka et
al., 2001). The inhibition of NO is found to be a key
mediator in the phenomenon of inflammation.
Thus R. cordifolia was evaluated for inhibitory
activity on NO produced in-vitro from sodium
nitroprusside, and in LPS-activated murine peritoneal
macrophages, ex vivo (Basu and Hazra, 2006). The
inhibition of NO synthesis was correlated with the
reduction of iNOS protein expression through
Western blot. Notable NO scavenging activity was
exhibited in vitro by extracts of R. cordifolia (IC50 < 0.2
mg/mL). It showed marked inhibition (60 - 80%),
ex vivo, at a dose of 80 ug/mL without appreciable
cytotoxic effect on the cultured macrophages.
Immunoblot analysis confirmed that the modulatory
effect of the samples had occurred through suppression
of iNOS protein suggestive of potential inhibition
of NO production.
Wound healing activity
Several drugs of plant, mineral and animal origin
are described in the Ayurveda for their wound
healing properties under the term vranaropaka.
R. cordifolia was also found to be effective in
experimental models (Biswas and Mukherjee, 2003).
Anti-allergic activity
Alcoholic extract of R. cordifolia inhibited passive
cutaneous anaphylaxis (PCA) in the mouse and rat
(Gupta et al., 1993).
Anticonvulsant activity
Triterpenes isolated from the acetone soluble part
of petroleum ether extract of R. cordifolia inhibited
seizures induced by maximum electroshock (MES),
electrical kindling, pentylenetetrazol (PTZ), and
lithium-pilocarpine. However seizures induced by
strychnine were not inhibited (Kasture et al., 2000).
Pentobarbitone-induced sleep
Mice treated orally with triterpenes isolated from
the petroleum ether extract of R. cordifolia significantly
prolonged the pentobarbitone-induced sleeping
time (Kasture et al., 2000).
Antinociceptive activity
Mice treated with triterpenes isolated from the
petroleum ether extract of R. cordifolia exhibited
significant antinociceptive activity as indicated by
increase in the reaction time in the hot plate
analgesiometer (Kasture et al., 2000).
Anxiolytic activity
Mice treated with triterpenes isolated from the
petroleum ether extract of R. cordifolia exhibited
anxiogenic activity by remaining for most of the
time in the closed arm 38. Whereas, the ethanolic
extract exhibited anxiolytic activity as indicated by
a significant increase in open arm occupancy
(Kasture et al., 2000).
Nootropic activity
Alcoholic extract of roots of R. cordifolia decreased
transfer latency in the elevated plus maze paradigm
suggesting nootropic activity. Alcoholic extract of
R. cordifolia antagonized amnesic effect of scopolamine
(Patil et al., 2006).
Effect on motor co-ordination
Alcoholic extract of roots of R. cordifolia significantly
decreased the fall off time when placed on rotarod
rotating at the speed of 20 rev/min (Patil et al., 2006).
Antistress activity
Alcoholic extract of roots of R. cordifolia significantly
decreased ulcer index, acidity, plasma corticosterone
level, brain content of dopamine in a dose-dependent
manner in animals under cold restraint stress
(CRS) when compared with diazepam. Alcoholic
extract of R. cordifolia increased brain content of
GABA in dose-dependent manner in CRS treated
animals (Patil et al., 2006).
Effect on baclofen induced catatonia
Alcoholic extract of R. cordifolia potentiated baclofen-
Rubia cordifolia: a review 11
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
induced catatonia (Patil et al., 2006).
Clinical studies
During recent studies in patients with eczema, the
topical application of the plant showed a 50%
reduction in the severity score within 4 days, the
oedema, exudation and itching being significantly
relieved (Antarkar et al., 1978).
Phase I Study of RA-700
Phase I clinical study was conducted on an
antitumour substance RA-700 isolated from Rubia
akane or R. cordifolia. This clinical study was
carried out in 6 institutions. The effects of a single
dose administration and 5-day administration
were evaluated in 14 patients. RA-700 was given
from 0.2 to 1.4 mg/M2 in single i.v. dose and from
0.4 to 2.0 mg/M2 in 5-day i.v. dose schedule. Nausea,
vomiting, fever, stomachache, mild hypotension
and slight abnormality of electrocardiogram were
observed. In pharmacokinetic study, the elimination
half-lives (t1/2) of RA-700 in plasma were: 55 min
of alpha-phase and 3.9 h of beta-phase by single
dose study, and 23 - 25 min of alpha-phase and
6 - 14 h of beta-phase by 5-day schedule study.
Accumulation was not found in 5-day schedule
administration and metabolites were not observed
in plasma and urine. It seems that RA-700 was
metabolized by the liver and excreted in the feces.
In conclusion, the maximum tolerated dose was 1.4
mg/M2 for 5-day schedule administration (Majima et
al., 1993).
Inhibition of Hepatitis B Surface Antigen Secretion
on Human Hepatoma Cells by Components of R.
The antiviral activity in the roots of R. cordifolia was
examined, and three naphthohydroquinones,
furomollugin, mollugin, and rubilactone were
isolated from it. Furomollugin and mollugin strongly
suppressed the secretion of hepatitis B surface
antigen (HBsAg), furomollugin and mollugin showed
IC50 = 2.0 μg/mL, in human hepatoma Hep3B cells
while having little effect on the viability of the cells.
A 6-hydroxy group and a pyran or furan ring
contribute to suppressive effect of furomollugin
and mollugin (Ho et al., 1996).
Abderrahman SM. (2004) Mitodepressive effect of
Rubia cordifolia extract on the bone marrow cells of
mice. Cytologia 69, 307-311.
Adwankar MK, Chitnis MP, Khandalekar DD, Bhadsavale
CG. (1980) Anti-cancer activity of the extracts of
Rubia cordifolia Linn. Indian J. Exp. Biol. 18, 102.
Adwankar MK, Chitnis MP. (1982) In vivo anti-cancer
activity of RC-18: a plant isolate from R. Cordifolia
Linn. against a spectrum of experimental tumour
models. Chemotherapy 28, 291-293.
Anonymous. (1999) The Wealth of India – Raw Materials,
PID, Council of Scientific and Industrial Research,
New Delhi, India. p. 82-83.
Antarkar DS, Shroff HJ, Bhatt NS. (1978) Treatment of
Eczema with Indigenous Drug Manjishtha-Rubia
cordifolia Linn. International Conference, Advances
in Internal- Medicine, Bombay (Abstracts).
Antarkar SS, Chinwalla T, Bhatt N. (1983) Anti-
inflammtory activity of Rubia cordifolia Linn. in rats.
Indian J. Pharmacol. 15, 185-188.
Bapalal NA. (1965) Shree Atmanand Sarasvati Ayurvedic
Pharmacy Ltd. 589.
Baskar R, Bhakshu L, Bharathi G, Reddy S, Karuna R,
Reddy G, Saralakumari D. (2006) Antihyperglycemic
Activity of Aqueous Root Extract of Rubia cordifolia
in Streptozotocin-Induced Diabetic Rats. Pharm.
Biol. 44, 475-479.
Basu S, Ghosh A, Hazra B. (2005) Evaluation of the
antibacterial activity of Ventilago madraspatana
Gaertn. Rubia cordifolia Linn. and Lantana camara
Linn.: isolation of emodin and physcion as active
antibacterial agents. Phytother. Res. 19, 888-894.
Basu S, Hazra B. (2006) Evaluation of nitric oxide
scavenging activity, in vitro and ex vivo, of selected
medicinal plants traditionally used in inflammatory
diseases. Phytother. Res. 20, 896-900.
Biswas TK, Mukherjee B. (2003) Plant medicines of
Indian origin for wound healing activity: a review.
Int. J. Low Extrem. Wounds 2, 25-39.
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
12 Rupali Patil et al.
Chang P, Chen C. (1995) Cytotoxic antileukemic
anthraquinones from Morinda umbellate include
alizarin-1-methyl ether, alizarin, manjistin methyl
ester and 2-hydroxy-anthraquinone-3-aldehyde. Chin.
Phar. J. 47, 347-353.
Chopra RN, Nayar SL, Chopra IC. (1957) In Glossary
of Indian Medicinal Plants, CSIR, New Delhi, India.
Dosseh C, Tessier AM. (1981) Nouvelles quinines des
raciness de Rubia cordifolia Linn. III. Planta med. 43,
Gilani AH, Janbaz KH, Zaman M, Lateef A, Suria A,
Ahmed HR.(1994) Possible presence of calcium
channel blocker(s) in Rubia cordifolia : an indigenous
medicinal plant J. Pak. Med. Asso. 44, 82-85.
Gilani AH, Janbaz KH. (1995) Effect of Rubia cordifolia
extract on acetaminophen and CCl4-induced
hepatotoxicity. Phytother. Res. 9, 372-375.
Gupta PP, Srimal RC, Tandon JS. (1993) Antiallergic
activity of some traditional Indian medicinal plants.
Int. J. Pharmacog. 31, 15-18.
Gupta PP, Srimal RC, Verma N, Tandon JS. (1999)
Biological Activity of Rubia cordifolia and Isolation
of an Active Principle. Pharm. Biol. 37, 46-49.
Halpern M. (2004) Cancer Part-III: Ayurvedic manageme nt,
California college of Ayurveda.
Ho LK, Don MJ, Chen HC, Yeh SF, Chen JM. (1996)
Inhibition of Hepatitis B Surface Antigen Secretion
on Human Hepatoma Cells. Components from
Rubia cordifolia. J. Nat. Prod. 59, 330-333.
Ho LK, Yub HJ, Hob CT, Don MJ. (2001) Synthesis of
naturally occurring Rubilactone, Mollugin and
Dihydromollugin of Rubia cordifolia. J. Chin. Chem.
Soc. 48, 77-79.
Ismail NH, Ali AM, Aimi N, Kitajima M, Takayama
H, Lajja NH. (1997) Anthraquinones from Morinda
elliptica. Phytochemistry 45, 1723-1725.
Itokawa H, Ibraheim ZZ, Ya-Fang Q, Takeya K. (1993)
Anthraquinones, naphthohydroquinones and naph-
thohydroquinone dimmers from RC and their cytotoxic
activity. Chem. Pharm. Bull. 41, 1869.
Itokawa H, Qiao YF, Takeya K, Itaka Y. (1989) New
triterpinoids from Rubia cordifolia var. pratensis
(Rubiaceae). Chem. Pharm. Bull. 37, 1670.
Itokawa H, Qiao YF, Takeya K, Itaka Y. (1990) Arborane
type triterpinoids from Rubia cordifolia var. pratensis,
and R. onchotrica. Chem. Pharm. Bull. 38, 1435.
Jain A, Basal E. (2003) Inhibition of Propionibacterium
acnes-induced mediators of inflammation by Indian
herbs. Phytomedicine 10, 34-38.
Jha MK. (1992) The folk veterinary system of Bihar- a
research survey. NDDB, Anand, Gujarat, India.
Joharapurkar AA, Zambad SP, Wanjari MM, Umathe
SN. (2003) In vivo evaluation of antioxidant activity
of alcoholic extract of Rubia cordifolia Linn and its
influence on ethanol-induced immunosuppression.
Indian J. Pharmacol. 35, 232-236.
Kasture VS, Deshmukh VK, Chopde CT. (2000)
Anticonvulsant and behavioral actions of triterpenes
isolated from Rubia cordifolia Linn. Indian J. Exp. Biol.
38, 675-680.
Kato T, Suzumura Y, Takamoto S, Ota K. (1987) Antitumo r
activity and toxicity in mice of RA-700, a cyclic
hexapeptide. Anticancer Res. 7, 329-334.
Khalid HJ. (1995) University of Karachi/Department
of Pharmacology. Investigation of hepatoprotective
activity of herbal constituents. Pakistan Research
Khare CP. (2004) Encyclopedia of Indian medicinal
plants, Rational Western Therapy & Other Traditional
Usage, Botany. Springerverlag Berlin Meidelberg,
p. 406-407.
Kirtikar KR, Basu BD. (1980) Indian Medicinal Plants.
Vol II. 2nd edition. International Book Distributors,
Dehradun, p. 1305-1307.
Koumaglo K, Gbeassor M, Nikabu O, Souza CD,
Werner W. (1992) Effects of three compounds extracted
from Morinda lucida on Plasmodium falciparum.
Planta Med. 58, 533-534.
Koyama J, Ogura T, Tagahara K, Konoshima T, Kozuka
M. (1992) Two naphthaquinones from Rubia cordifolia.
Phytochemistry 31, 2907-2908.
Majima H, Tsukagoshi S, Furue H, Suminaga M,
Sakamoto K, Wakabayashi R, Kishino S, Niitani H,
Murata A, Genma A. (1993) Phase I Study of RA-
700. Gan To Kagaku Ryoho. 20, 67-78.
Morita H, Yamamiya T, Takeya K, Itokawa H. (1992)
New antitumour bicyclic hexapeptides, RA-XI, -XII,
-XIII and –XIV from Rubia cordifolia. Chem. Pharm.
Bull. 40, 1352-1354.
Morita H, Yamamiya T, Takeya K. (1993) Conformational
Recognition of RA – XII by 80S ribosomes: a different
line broadening study in 1H NMR spectroscopy.
Chem. Pharm. Bull. 41, 781.
Nadkarni KM. (1976) Indian Materia Medica, Vol. 1.
Rubia cordifolia: a review 13
2009 Oriental Pharmacy and Experimental Medicine 9(1), 1-13
Papular Prakashan, Bombay. 1075.
Patil RA, Jagdale SC, Kasture SB. (2006) Antihy-
perglycemic, antistress and nootropic activity of roots
of Rubia cordifolia, Linn. Indian J. Exp. Biol. 44, 987-992.
Qiao YE, Wang SX, Wu LJ, Li X, Zhu TR. (1990) Studies
on antibacterial constituents from the roots of Rubia
cordifolia Linn. Acta Pharm. Sinica 25, 834-838.
Rao GM, Rao CV, Pushpangadan P, Shirwaikar A.
(2006) Hepatoprotective effects of rubiadin, a major
constituent of Rubia cordifolia Linn. J. Ethnopharmacol.
103, 484-490.
Rastogi RP, Dhawan BN. (1990) Anticancer and antiviral
activities in Indian medicinal plants: A review. Drug
Dev. Res. 19, 1-12.
Rath G, Ndonzao M, Hostettmann K. (1995) Antifungal
activity against Cladosporium and Candida by
anthraquinones (especially alizarin-1-methyl ether)
from dichloromethane extract of Morinda lucida. Int.
J. Pharmacog. 33, 107.
Samatha S, Vasudevan TN. (1996) Natural hair dyes.
J. Sci. Ind. Res. 55, 885-887.
Singh R, Jain A, Panwar S, Gupta D, Khare SK. (2005)
Antimicrobial activity of some natural dyes. Dyes
Pigments 66, 99-102.
Sittie A, Lemmich E, Olsen CE, Hviid L, Kharazmi A,
Nkrumah FK, Christensen SB. (1999) Structure-
activity studies: in vitro antileishmanial and antimalarial
activities of anthraquinones from Morinda lucida.
Planta Med. 65, 259-261.
Somani R, Vadnere G, Jain K, Singhai A. (2006) Effect
of Rubia cordifolia on blood glucose level and
glucose utilization by isolated rat hemidiaphragm.
Planta Med. 72, 1055.
Son JK, Jung JH, Lee CS, Moon DC, Choi SW, Min BS,
Woo MH. (2006) DNA Topoisomerases I and II
Inhibition and Cytotoxicity of Constituents from
the Roots of Rubia cordifolia. Chem. Inform. 38.
Takeya K, Yamamiya T, Morita H, Itokowa H. (1993)
Two antitumour bicyclic hexapeptides from Rubia
cordifolia. Phytochemistry 33, 613-615.
Tezuka Y, Irikawa S, Kaneko T, Banskota AH, Nagaoka
T, Xiong Q, Hase K, Kadota S. (2001) Screening of
Chinese herbal drug extracts for inhibitory activity
on nitric oxide production and identification of an
active compound of Zanthoxylum bungeanum. J.
Ethnopharmacol. 77, 209-217.
Thomson RH. (1971) Naturally Occurring Quinones,
2nd Ed., Academic Press, London.
Tripathi YB, Pandey S, Shukla SD. (1993) Anti-platelet
activating factor property of Rubia cordifolia Linn.
Indian J. Exp. Biol. 31, 533-535.
Tripathi YB, Sharma M, Manickam M. (1997) Rubiadin, a
new antioxidant from Rubia cordifolia. Ind. J. Biochem.
Biophys. 34, 302-306.
Tripathi YB, Sharma M, Shukla S, Tripathi P, Thyagaraju
K, Reddanna P. (1995) Rubia cordifolia inhibits potato
lipoxygenase. Indian J. Exp. Biol. 33, 109-112.
Tripathi YB, Shukla SD. (1998) Rubia cordifolia extract
inhibits cell proliferation in A- 431 cells. Phytother.
Res. 12, 454-456.
Tripathi YB, Singh AV. (2007) Role of Rubia cordifolia
Linn. in radiation protection. Indian J. Exp. Biol. 45,
Tse WP, Chun-Tao Che, Ken Liu, Zhi-Xiu Lin. (2006)
Evaluation of the antiproliferative properties of
selected psoriasis-treating Chinese medicines on
cultured HaCaT cells. J. Ethnopharmacol. 108, 133-
Vidal-Tessier AM, Delaveau P, Champion B. (1986)
New quinones of Rubia cordifolia L. roots. Ann. Pharm.
Fr. 44, 117-122.
Vlietinck AJ, Hoof L, Totte J, Lasure A, Berghe D,
Rwangabo PC, Mvukiyumwami J. (1995) Screening
of hundred Rwandese medicinal plants for
antimicrobial and antiviral properties. J. Ethnopharmacol.
46, 31-47.
Williams EM. Major Herbs of Ayurveda. Compiled
by The Dabur Research Foundation & Dabur Ayurvet
Limited, Ghaziabad, India, Churchill Livingstone,
An Imprint of Elsevier Science Limited. p. 257-260.
Wu LJ, Wang SX, Hua HM. (1991) 6- methoxygeniposidic
acid, an iridoid glycoside from Rubia cordifolia.
Phytochemistry 30, 1710.
Younos C, Rolland A, Fleurentin J, Lanhers M, Misslin
R, Mortier F. (1990) Analgesic and behavioral effects of
Morinda citrifolia. Planta Med. 56, 430-434.
Zhang ZH. (1983) Clinical observation on the increase
of leukocyte count in leucopenia promoted by
diethylester Rubia cordifolia L. Zhong Xi Yi Jie He Za
Zhi 3, 98-99.
... In Ayurveda, R. cordifolia has been used as a coloring agent for medicinal oils, and applied externally to inflamed areas, ulcers and fractures. R. cordifolia root has been treated various chronic inflammations (Deshkar et al., 2008;Patil et al., 2009). A paste made from honey is applied to the skin to remove brown spots, freckles and other skin discoloration and is used to promote wound healing (Adwankar et al., 1980;Pawar et al., 2009). ...
... In Uganda medicine, traditional healers use the drug to treat tuberculosis cases. In the Philippines medicine, root decoction of R. cordifolia is used to treat urinary tract disorders (Patil et al., 2009). In traditional Asian medicine, the roots of R. cordifolia have become an important drug for the treatment of abnormal uterine bleeding (AUB), purpura lupus erythematosus, hemorrhage syndrome, arthritis, kidney stones, hemostasis, hysteresis, and psoriasis (Chang et al., 2000;Basu et al., 2005;Tse et al., 2007;Son et al., 2008;Wang K. et al., 2020). ...
Full-text available
Rubia cordifolia (family: Rubiaceae) L (R. cordifolia) is a perennial botanical drug climbing vine. As the main part of the traditional Chinese medicine, the rhizome has a long history. A great number of literary studies have reported that it can be used for the improvement of blood circulation, hemostasis, activation of collaterals, etc. When it comes to the wide application of R. cordifolia in traditional medicine, we systematically review its traditional uses, phytochemistry and pharmacological effects. Literatures were systematically searched using several scientific databases, including China National Knowledge Infrastructure (CNKI), Baidu Scholar, PubMed, Web of Science, and other professional websites. Kew Botanical Garden and the iPlant were used for obtaining the scientific names and plant images of R. cordifolia. In addition, other information was also gathered from books including traditional Chinese herbal medicine, the Chinese Pharmacopoeia, and Chinese Materia Medica. So far, many prescriptions containing R. cordifolia have been widely used in the clinical treatment of abnormal uterine bleeding, primary dysmenorrhea and other gynecological diseases, allergic purpura, renal hemorrhage and other diseases. The phytochemistry studies have reported that more than 100 compounds are found in R. cordifolia, such as bicyclic peptides, terpenes, polysaccharides, trace elements, flavonoids, and quinones. Among them, quinones and peptides are the types of components with the highest contents in R. cordifolia. The modern pharmacological studies have revealed that R. cordifolia and its derived components have anti-tumor, anti-oxidative, anti-platelet aggregation, and anti-inflammatory effects. However, most studies are preclinical. The pharmacological mechanism of R. cordifolia has not been thoroughly studied. In addition, there are few pharmacokinetic and toxicity studies of R. cordifolia, therefore the clinical safety data for R. cordifolia is lacking. To sum up, this review for the first time summarizes a systemic and integrated traditional uses, chemical compositions, pharmacological actions and clinical applications of R. cordifolia, which provides the novel and full-scale insight for the drug development, medicinal value, and application of R. cordifolia in the future.
... usage -Comme quelques autres espèces du genre, R. cordifolia, -la garance indienne -, était souvent cultivée, surtout en Inde jusqu'au XIX e siècle, pour obtenir un colorant rouge à partir de ses racines. L'espèce joue aussi un rôle en médecine ayurvédique (voir Patil & al. 2009). En Afrique, sa culture n'a pas été pratiquée (voir Zimudzi 2005). ...
... Ici, nous suivons Verdcourt (1976) et Puff (1984 qui ont proposé de considérer les populations africaines subsahariennes, relativement homogènes morphologiquement, comme représentant une seule sous-espèce. Patil & al. (2009), Puff (1984, Verdcourt (1975Verdcourt ( , 1976Verdcourt ( , 1989, Zimudzi (2005). ...
A flora treatment is provided for two tribes of the Rubiaceae subfamily Rubioideae, the Anthospermeae and Rubieae, with identification keys, descriptions of the species (five in Anthospermeae, eleven in Rubieae), data on synonyms, chorology, habitat, vernacular names and uses. Representative herbarium specimens and references to additional literature are given. All this is supplemented with seven detailed drawings and six colour plates to support the identification. Anthospermum is the only genus of the tribe Anthospermeae occurring in the Democratic Republic of Congo, Rwanda and Burundi. In a recent molecular study, the genus was shown not to be monophyletic, the related genus Nenax being deeply nested within a clade of southern African Anthospermum species. In case of future splitting, the generic name Anthospermum will, however, remain applicable to the species represented in the area covered by this Flora. These are: the widely spread A. herbaceum, A. welwitschii, and A. usambarense. The presence of two further species within the Flora region, A. rosmarinus and A. ternatum, needs to be confirmed. In Central Africa, the essentially temperate tribe Rubieae is represented by afromontane to afroalpine elements of the genera Rubia and Galium. The first genus is represented by Rubia cordifolia only, while ten species of Galium exist in the Flora region. They are afro(sub)montane (G. bussei, G. chloroionanthum, G. scabrellum, G. scioanum, G. spurium subsp. africanum, G. stenophyllum), afrosubalpine (G. chloroionanthum, G. scabrellum, G. simense, G. thunbergianum) or afroalpine (G. glaciale, G. ruwenzoriense). Unresolved taxonomic issues are mentioned for Galium bussei, G. ruwenzoriense, G. scabrellum and G. spurium. Recent molecular studies pointed to the need of a future splitting of the large genus Galium. It is not clear at present whether in that case the species dealt with in this Flora will keep their present name under Galium.
... Changes in duration of cycle, duration of flow and amount of flow was achieved in 66.7%, 96.7%, 86.7% patients respectively, and weight reduction in 60% patients (Table 7). hepato-protective activity, anti-cancer, antioxidant, anti-inflammatory, insulin sensitizer and stimulating effect on uterine muscle fibres due to presence of active ingredient such as cinnamic acid, cinamaldehyde, eugenol, essential oil, tanins, rubiadin, methanol extract [34][35][36] alloxan, triterpenoids, rubimalin saponins, Anthraquinone and their glycosoids, quinone and flavonoids, [37] Finally, it can be concluded that the research drug formulation studied can be used as alternate remedy in PCOD patients, as it has significant effect in menstrual cyclicity by reduction of weight and probably by improving the insulin resistance in PCOD. ...
... 104 Roots have tonic, antidysentery, astringent, and antiseptic properties. 105 The roots of manjistha are effective in preventing the kidney stones. They function by lowering the calcium and oxalate level in kidneys and inhibit the formation of urinary stones. ...
Full-text available
Kidney stones are among the oldest and most widespread urinary tract ailments, impacting people all over the globe with a high recurrence rate. The mechanism of kidney stone formation includes events such as urine supersaturation, aggregation, retention, nucleation, and growth of crystals in the cells of the renal tubular epithelium. Kidney stones may cause extreme pain and blockage of urine flow. They are usually treated with synthetic drugs and extracorporeal shock wave lithotripsy (ESWL) as well as a variety of medications that may cause several adverse effects. The remaining stone fragments and the risk of infection following ESWL are severe problems in the treatment of kidney stones. Recently, despite the emergence of synthetic drugs, medicinal plants have been recognized and utilized in many nations due to their safety profile, efficiency, cultural acceptance, and fewer side effects than synthetic drugs. Medicinal plants are used in different cultures as a reliable source of natural remedies. The aim of this review is to provide comprehensive information about traditionally used antiurolithiatic plants as well as their scientifically proven pharmacological activities, their primary chemical ingredients, and potential mechanisms of action, such as analgesic, astringent, demulcent, diuretic activity, antioxidant activity, inhibition of the inflammatory process, nucleation inhibition, crystallization inhibition, inhibition of crystal aggregation, reducing hyperoxaluria, reducing stone size, and reducing urine supersaturation.
... An earlier study reported that rubiadin possesses strong antioxidant property and hence inhibit the lipid peroxidation process which is induced by FeSO 4 and t-butyl-hydroperoxide [37]. Rubiadin also possesses strong anti-inflammatory, immune-modulatory, anticonvulsant, anxiolytic, and anti-diabetic activity [38]. In earlier finding, rubiadin and rubiadin 1-methyl ether were proved to be good constituents of Morinda citrofolia. ...
Full-text available
Diabetic nephropathy (DN) is a significant source of end-stage renal illness all over the world in both developed and developing countries. The aim of the study was to optimize rubiadin-loaded niosomes (RLN) using Box-Behnken design for the management of streptozotocin-nicotinamide (STZ-NA)-induced DN in Wistar rats. The RLN were formulated by a “thin-layer hydration technique.” The optimization of RLN was done by Box-Behnken design; the independent variables were cholesterol (CHOL), Span 80, and methanol, while the dependent factors were the vesicle size, zeta potential, and entrapment efficiency. The optimized formulation was characterized for various biochemical parameters including anti-diabetic activity in Wistar rats. The optimized RLN presented vesicle size of 238 nm, zeta potential −68 mV, and entrapment efficiency 85%. A noteworthy decreased in blood glucose level was detected in STZ-NA-induced DN rats when orally treated with RLN (100 mg/kg/week and 200 mg/kg/week). Oral administration of RLN formulation considerably decreased the levels of urea, uric acid, and creatinine in DN rats. In addition, treatment of DN rats with RLN formulation considerably improves the level of TBARS, GSH, SOD, and CAT. The lipid profile of DN rats was also improved on treatment with RLN formulation. This study revealed that the prepared RLN formulation was successfully optimized by Box-Behnken design and found to be useful for the management of STZ-NA-induced DN in Wistar rats.Graphical abstract
Plants and their bioactive compounds are used in medicinal practices since ancient times. The Himalayan region possesses a large number of medicinal plants, which have been used to prevent and cure several human diseases. Diabetes is a major public health problem, which affects millions of people worldwide. Due to its complexity and impact on whole body hemodynamics, there is no cure for any type of diabetes, and most of the available drugs only help manage the symptoms to a certain extent. Moreover, the development of drug with lesser or no side effects is still a challenge to the medical system. Plant products and their derived active compounds can be possible alternatives for the treatment of diabetes without much adverse effects. Therefore, analysis on such plants and their metabolites has become important. However, routine efforts to identify the plant-based active compounds are not sufficient and there is a need for more rigorous scientific validation to ensure their efficacy, safety, and consistency. In addition, analysis of the chemical structure of a bioactive compound and its relationship with biological activity (structure–activity relationship or SAR) is crucial as it allows the modification of the bioactive compound by changing its chemical structure; this can be considered as a powerful tool in the discovery of drugs, which are very selective and have less side effects. Although several plant-based medicines are being used traditionally for treating diabetes and have been scientifically validated, their mechanism of action is yet to be defined. Here, we review several plant species of the Himalayan region that can be effectively used to treat diabetes and their bioactive compounds having antidiabetic properties and discuss their structure–activity relationship and probable molecular mechanism underlying these properties.
Background Recent findings indicated that electron mediating characteristics of electrochemical catalysis would enhance disease-treating efficacy of herbal medicine. In particular, biomass energy-amplifying and electron transfer-stimulating medicines could even treat not only brain-associated diseases, but also virus-caused infections. Exploring different electron shuttle (ES)-bearing medicinal herbs for biorefinery should have potentials to develop value-added production (e.g., medicated diet). Methods Microbial fuel cells (MFCs) were used as the bioenergy-evaluating platform to select the most promising anthraquinone (AQ) ES-abundant herb. Optimal conditions of water and ethanol extraction were determined to maximize bioenergy content of resultant extract. According to HPLC, MS/MS and TAC analyses, serial acclimation to select effective rhubarb-degrading bacteria was implemented to maximize the product formation. Significant findings Rheum palmatum L. was the most favorable AQ-plentiful medicinal herb to exhibit bioenergy-stimulating activities. Extraction at higher ethanol % could obtain the maximal recovery of AQ content; however, an increased inhibition was resulted as MFC results indicated. With 3-4 cycles of acclimation using appropriate food-originated microbes, the production of aloe-emodin and chrysophanol increased ca. 400% and 270%, respectively. To the best of our knowledge, this first-attempt study provided a novel bioenergy perspective to maximize AQ production of rhubarb fermentation. Moreover, significant reduction of biotoxicity potency should be top-priority concern to guarantee this GRAS production.
For ages, the Himalayan mountain range of the Tibetan Plateau has harboured a unique diversity of endemic medicinal flora, establishing the region as a major hotspot of ethnobotanical biodiversity. The numbers, analysis, and documentation of traditional Himalayan plants have increased rapidly in recent decades, but a lot of work is still in progress. In high-altitude regions, the local medicinal practitioners are the prime conservers of medicinal plants, and their main work of preparing herbal formulations and identifying related therapeutic uses depends solely on ancestral knowledge gained since the Vedic period. Out of the main list, several Himalayan medicinal plants such as Achillea wilhelmsii, Caesalpinia bonducella, Jatropha curcas, Picrorhiza scrophulariiflora, Plantago asiatica, Panax ginseng, Sophora subprostrata, Morus alba, Withania somnifera, and Tinospora cordifolia are well known for their importance in stimulating immunity. Therefore, the present chapter is an attempt for highlighting the history, composition of local herbal formulations, and ethnopharmacology of Himalayan medicinal plants for enhancing human immune systems.
Full-text available
Medicinal herbs have a rich history of their utilization for variety of ailments. India is categorized among those countries which have produced vast variety of medicinal plants. India is also called as “Botanical garden of the world”. Medicinal plants are the source of discovery of new drugs across the world. Most of the drugs available today have some herbal content of plants in them. Rubia Cordifolia (Manjishtha) is a climber herb having small flowers of greenish white colour which are grouped around the purplish fleshy fruits. The roots of Rubia cordifolia imparts red colour from where dye is obtained which is due to the presence of brownish red bark. This plant is mainly cultivated in the hilly areas. Manjishtha has a very significant place in Ayurveda which is one of the most ancient health care systems of the world. Charaka categorized this medicinal herb as varnya (for the enhancement of skin complexion), jvarahara (anti-pyretic), visaghna (a detoxifier) and a rasayana (rejuvenator). While it is categorized as pittasamsamana (one which maintains the pitta dosha of the body i.e. the fire component of the body) by Acharya Sushrut. Manjishtha has potential to pacifiy the pitta dosha. The phytochemical constituents of Rubia Cordifolia (Manjishtha) are associated with wide range of therapeutic properties. In this review, summary of its phytochemistry, its uses in different medicinal systems like Ayurveda and folk system and its scientific therapeutic properties are reported.
Full-text available
Rubia cordifolia, Linn; Indian Manjishtha was studied for the anti-inflammatory effect in rats with carrageenan paw edema. The plant showed significant anti-inflammatory activity at a dose of 10 and 20 ml/-kg of the water extracts. The activity was comparable to that of phenylbutazone (100 mg/kg). No such activity was observed with Rubia tinctorum- the Iranian variety of Manjishtha.
Full-text available
Objective: To evaluate the in vivo antioxidant activity of alcoholic extract of the roots of Rubia cordifolia Linn. (RC) and to study its influence on ethanol-induced impairment of immune responses. Methods: The ethanol-treated (2 g/kg, 20% w/v, p.o., daily for four weeks) rats concurrently received either RC or a combination of vitamin E and C (each 100 mg/kg, p.o.) daily for the same period. The parameters like phagocytosis, total leukocyte count (TLC), humoral and cell-mediated immune responses, lipid peroxidation (LPO), reduced glutathione (GSH) content, superoxide dismutase (SOD) and catalase (CAT) activities were assessed. Results: Chronic administration of ethanol decreased the humoral and cell-mediated immune response, phagocytosis, phagocytosis index, TLC, GSH, CAT and SOD activities and increased the LPO. These influences of ethanol were prevented by concurrent daily administration of RC and the effect was comparable with that of the combination of vitamin E and C. Conclusion: The ethanol-induced immunosuppression is due to oxidative stress and Rubia cordifolia can prevent the same by virtue of its in vivo antioxidant property.
The extracts of Pterocarpus santalinus, Rubia cordifolia and embelic acid isolated from Embelia ribes were studied for their ability to dye hair. The retention of dye was observed by shampooing the hair switches once-a-day for 15 d. The dye extracts were also mixed with an iron mordant to get different shades.
This chapter is an enlarged combination of Chapters 4 and 5 in NOQ III and deals with the fully aromatic phenanthrenequinones, napthacenequinones and benz[a]anthraquinones, and their ring-A reduced analogues—the anthracyc-linones and angucyclinones—both of which exist in substantial num- bers. The smaller group of benz[a]napthacenequinones is also covered, and finally the extended polycyclic quinones including the ancient quincyte pigments.
The structures of six new arborane type triterpenoids, rubiarbonols A, B, C, D, E, and F, from Rubia plants were determined as 3β, 7β, 19α, 28-tetrahydroxyarbor-9(11)-ene, 3β, 7β, 19α-trihydroxyarbor-9(11)-ene, 2α-acetoxy-3β, 7β, 19α-trihydroxyarbor-9(11)-ene, 3β-acetoxy-2α, 7β, 19α-trihydroxyarbor-9(11)-ene, 2α, 3β, 7β, 19α-tetrahydroxyarbor-9(11)-ene, and 2α, 3β, 7β, 19α, 28-pentahydroxyarbor-9(11)-ene respectively by various spectroscopic methods.
From the roots of Rubia cordifolia var. pratensis, three new triterpenoids named rubiprasins A, B and C have been isolated and their structures were determined as 3β-acetoxyoleanane-13β, 15α-diol-12-one, 3β-acetoxyoleanace-13β-ol-12-one and 3β-acetoxyl-19α-hydroxyolean-12-en-28-oic acid respectively by various chemical and spectroscopic methods including 1H-1H COSY, 1H-13C COSY and X-ray diffractions.